Teva Pharmaceutical Industries Ltd
TASE:TEVA
Teva Pharmaceutical Industries Ltd
Tax Provision
Teva Pharmaceutical Industries Ltd
Tax Provision Peer Comparison
Competitive Tax Provision Analysis
Latest Figures & CAGR of Competitors
Company | Tax Provision | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
T
|
Teva Pharmaceutical Industries Ltd
TASE:TEVA
|
Tax Provision
$7m
|
CAGR 3-Years
-65%
|
CAGR 5-Years
-53%
|
CAGR 10-Years
-17%
|
Taro Pharmaceutical Industries Ltd
NYSE:TARO
|
Tax Provision
-$28.6m
|
CAGR 3-Years
4%
|
CAGR 5-Years
16%
|
CAGR 10-Years
10%
|
|
I
|
InterCure Ltd
TASE:INCR
|
Tax Provision
₪12m
|
CAGR 3-Years
1 717%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Mediwound Ltd
NASDAQ:MDWD
|
Tax Provision
-$185k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
R
|
Rekah Pharmaceutical Industry Ltd
TASE:REKA
|
Tax Provision
-₪1.8m
|
CAGR 3-Years
11%
|
CAGR 5-Years
6%
|
CAGR 10-Years
5%
|
C
|
Cannassure Therapeutics Ltd
TASE:CSURE
|
Tax Provision
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Teva Pharmaceutical Industries Ltd's Tax Provision?
Tax Provision
7m
USD
Based on the financial report for Dec 31, 2023, Teva Pharmaceutical Industries Ltd's Tax Provision amounts to 7m USD.
What is Teva Pharmaceutical Industries Ltd's Tax Provision growth rate?
Tax Provision CAGR 10Y
-17%
Over the last year, the Tax Provision growth was -99%. The average annual Tax Provision growth rates for Teva Pharmaceutical Industries Ltd have been -65% over the past three years , -53% over the past five years , and -17% over the past ten years .